Skip to main content

Table 1 Characteristics of NPs as synthesized and their solvents

From: Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

Nanoparticle Composition

Mean Diameter (nm)

Surface Coating

Concentration

Solvent

   

NPs/ml

μg/ml

nM

 

Gold (Au)

4

Citrate ions

5 × 1013

56.7

83.1

Na Citrate 0.25 mM; oxidised NaBH4 0.3 mM; pH 8

Gold (Au)

13

Citrate ions

1012

62.7

1.7

Na Citrate 2.2 mM; pH 7

Gold (Au)

20

Citrate ions

1012

100.0

1.7

Na Citrate 0.85 mM; pH 7

Silver (Ag)

30

Citrate ions

1012

107.8

1.7

Na Citrate 10 mM; pH 7

Silver Oxide (AgO)

10-60

OH ions

1012

107.8

1.7

Oxidized NaBH4 2.64 mM; pH 9

Iron Oxide (Fe3O4)

7

TMAOH

1014

67.0

166.1

Tetramethylammonium Hydroxide (TMAOH) 5 mM; pH 10

Cobalt Oxide (CoO)

7

TMAOH

1014

38.1

166.1

TMAOH 1 mM; pH 9

Cerium Oxide (CeO2)

7

TMAOH

5 × 1013

14.0

83.1

TMAOH 1 mM; pH 9

Silver (Ag)

80

Citrate ions

1.1 × 109

3.1

N.D.

Na Citrate 20 μM

Gold (Au)

50-100

None

N.D.

200

N.D.

None

Cerium Oxide (CeO2)

15-30

None

N.D.

200

N.D.

None

Cobalt Oxide (CoO)

28

None

N.D.

200

N.D.

None

FexOy

20-50

None

N.D.

200

N.D.

None